Insufficient scRNA-seq data for expression of IL17C at single-cell level.
Insufficient scRNA-seq data for expression of IL17C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 90% | 9.72 | 520 / 578 | 19% | 1.26 | 220 / 1155 |
spleen | 98% | 17.96 | 236 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 12.45 | 804 / 929 | 0% | 0 | 0 / 0 |
stomach | 57% | 9.45 | 206 / 359 | 29% | 2.59 | 82 / 286 |
intestine | 54% | 3.66 | 521 / 966 | 26% | 1.21 | 135 / 527 |
bladder | 52% | 1.76 | 11 / 21 | 19% | 0.80 | 98 / 504 |
ovary | 46% | 1.54 | 82 / 180 | 23% | 0.85 | 101 / 430 |
brain | 68% | 5.67 | 1794 / 2642 | 1% | 0.01 | 4 / 705 |
esophagus | 39% | 3.83 | 564 / 1445 | 28% | 1.93 | 51 / 183 |
prostate | 64% | 3.56 | 156 / 245 | 2% | 0.04 | 12 / 502 |
uterus | 51% | 1.70 | 86 / 170 | 14% | 0.57 | 66 / 459 |
skin | 61% | 12.55 | 1110 / 1809 | 0% | 0.00 | 1 / 472 |
kidney | 61% | 2.28 | 54 / 89 | 0% | 0.01 | 2 / 901 |
thymus | 58% | 3.19 | 378 / 653 | 2% | 0.02 | 10 / 605 |
pancreas | 47% | 1.77 | 155 / 328 | 12% | 0.35 | 21 / 178 |
adipose | 56% | 2.48 | 679 / 1204 | 0% | 0 | 0 / 0 |
breast | 48% | 1.93 | 221 / 459 | 4% | 0.11 | 43 / 1118 |
liver | 40% | 1.36 | 90 / 226 | 0% | 0.01 | 2 / 406 |
blood vessel | 39% | 1.39 | 514 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 33% | 0.97 | 85 / 258 | 0% | 0.01 | 1 / 230 |
heart | 21% | 0.57 | 181 / 861 | 0% | 0 | 0 / 0 |
muscle | 21% | 0.60 | 168 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.78 | 6 / 29 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.18 | 6 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006954 | Biological process | inflammatory response |
GO_0007267 | Biological process | cell-cell signaling |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IL17C |
Protein name | Interleukin-17C (IL-17C) (Cytokine CX2) |
Synonyms | UNQ561/PRO1122 |
Description | FUNCTION: Cytokine that plays a crucial role in innate immunity of the epithelium, including to intestinal bacterial pathogens, in an autocrine manner. Stimulates the production of antibacterial peptides and pro-inflammatory molecules for host defense by signaling through the NF-kappa-B and MAPK pathways. Acts synergically with IL22 in inducing the expression of antibacterial peptides, including S100A8, S100A9, REG3A and REG3G. Synergy is also observed with TNF and IL1B in inducing DEFB2 from keratinocytes. Depending on the type of insult, may have both protective and pathogenic properties, either by maintaining epithelial homeostasis after an inflammatory challenge or by promoting inflammatory phenotype. Enhanced IL17C/IL17RE signaling may also lead to greater susceptibility to autoimmune diseases. . |
Accessions | ENST00000244241.5 Q9P0M4 |